26,619 Shares in Amedisys, Inc. (NASDAQ:AMED) Acquired by Quarry LP

Quarry LP acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 26,619 shares of the health services provider's stock, valued at approximately $2,569,000. Amedisys accounts for about 0.7% of Quarry LP's investment portfolio, making the stock its 28th biggest holding. Quarry LP owned 0.08% of Amedisys as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Point72 DIFC Ltd bought a new stake in shares of Amedisys during the third quarter valued at approximately $371,000. Polar Asset Management Partners Inc. acquired a new stake in Amedisys during the third quarter worth $28,953,000. Holocene Advisors LP increased its holdings in Amedisys by 391.4% in the 3rd quarter. Holocene Advisors LP now owns 79,036 shares of the health services provider's stock valued at $7,628,000 after buying an additional 62,953 shares during the period. ClearAlpha Technologies LP lifted its holdings in shares of Amedisys by 19.3% during the 3rd quarter. ClearAlpha Technologies LP now owns 77,861 shares of the health services provider's stock worth $7,514,000 after acquiring an additional 12,612 shares during the period. Finally, Bardin Hill Management Partners LP boosted its position in shares of Amedisys by 3.2% during the 3rd quarter. Bardin Hill Management Partners LP now owns 124,342 shares of the health services provider's stock valued at $12,000,000 after acquiring an additional 3,871 shares in the last quarter. Institutional investors own 94.36% of the company's stock.

Amedisys Price Performance

NASDAQ:AMED traded up $0.43 during mid-day trading on Thursday, hitting $85.41. The company's stock had a trading volume of 567,588 shares, compared to its average volume of 370,101. The company has a market capitalization of $2.80 billion, a price-to-earnings ratio of 33.72, a P/E/G ratio of 1.82 and a beta of 0.73. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a fifty-two week low of $84.06 and a fifty-two week high of $98.95. The stock has a fifty day moving average of $94.17 and a 200-day moving average of $95.46.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.19). The company had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.98 EPS. As a group, equities analysts forecast that Amedisys, Inc. will post 4.53 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.